Key Takeaways:This investment represents a key milestone in Robertet’s innovation strategy and its first step in biotech.Entering plant-based biotechnologies reaffirms its commitment to solutions that combine nature and cutting-edge technology.Aethera will benefit from Robertet’s global networks of clients and commercial capabilities.Through this strengthened partnership, Robertet initiates a new, targeted biotech strategy to develop advanced cosmetic active ingredients.WHO: Founded in 2016, Aethera Biotech is a subsidiary of the Italian family-owned group Cereal Docks, specializing in primary agro-food transformation. Aethera Biotech specializes in the research, development, and production of active ingredients derived from cell multiplication processes, primarily for the cosmetics and health markets. It is a pioneer in phyto-complex biotechnologies through its proprietary, multi-patented CROP (Controlled Release of Optimized Plants) platform. Inspired by natural plant mechanisms, this technology enables the secure production of natural extracts in controlled conditions, independent of climatic, agricultural, or geopolitical constraints. Based in Camisano Vicentino, Aethera Biotech employs a team of 25 professionals with complementary expertise, covering all biotech functions from R&D to industrialization. Its innovation is protected by a robust intellectual property portfolio comprising eight patents covering both products and the proprietary CROP technology.Founded in 1850 in Grasse, Robertet S.A. is the world leader in natural products. Headquartered in France and majority family-owned since its creation, the Group is controlled by the Maubert family.